Challenges and impact of conducting vaccine trials in Asia and Africa

Posted on by

Human Vaccines & Immunotherapeutics (formerly Human Vaccines)
Volume 9, Issue 4  April 2013
http://www.landesbioscience.com/journals/vaccines/toc/volume/9/issue/4/

SPECIAL FOCUS MEETING REPORTS – World Vaccine Congress 2012
Challenges and impact of conducting vaccine trials in Asia and Africa: New Technologies in Emerging Markets, October 16th-18th 2012; World Vaccine Congress, Lyon
Sonali Kochhar
http://dx.doi.org/10.4161/hv.23405

Abstract:
Immunization is one of the most beneficial and cost-effective disease prevention measures. There are global efforts to develop new vaccines for disease control. The vaccine clinical trials must be conducted in the countries where they will be used. This has led to vaccine trials being conducted across Asia and Africa where there is a high burden of infectious diseases. The setup and successful conduct of International standard GCP vaccine trials across trial centers located in resource constrained settings are challenging. The challenges, ethical considerations and impact of the implementation of clinical trials in low-resource settings are highlighted here to help vaccine development programs successfully conduct such trials.